| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 处方药类(元) | 359,963,542.04 | 792,862,533.36 | 235,849,737.96 | 663,884,422.30 | 344,360,173.27 |
| 非处方药类(元) | 1,550,271,538.65 | 3,265,753,958.90 | 1,725,109,073.76 | 3,050,072,545.59 | 1,646,417,842.53 |
| 保健品及其他(元) | 228,495,056.61 | 345,323,443.95 | 193,952,127.85 | 649,938,724.87 | 284,818,304.19 |
| 营业成本(元) | |||||
| 处方药类(元) | 204,987,465.01 | 481,288,556.82 | 118,831,829.22 | 244,214,394.15 | 103,408,092.06 |
| 非处方药类(元) | 369,864,366.27 | 890,171,826.41 | 430,333,819.13 | 863,287,475.30 | 437,016,384.15 |
| 保健品及其他(元) | 139,796,927.85 | 215,080,647.36 | 114,549,972.21 | 407,648,035.42 | 183,976,103.91 |
| 毛利(元) | |||||
| 处方药类(元) | 154,976,077.03 | 311,573,976.54 | 117,017,908.74 | 419,670,028.15 | 240,952,081.21 |
| 非处方药类(元) | 1,180,407,172.38 | 2,375,582,132.49 | 1,294,775,254.63 | 2,186,785,070.29 | 1,209,401,458.38 |
| 保健品及其他(元) | 88,698,128.76 | 130,242,796.59 | 79,402,155.64 | 242,290,689.45 | 100,842,200.28 |
| 毛利率(%) | |||||
| 处方药类(%) | 43.05 | 39.30 | 49.62 | 63.21 | 69.97 |
| 非处方药类(%) | 76.14 | 72.74 | 75.05 | 71.70 | 73.46 |
| 保健品及其他(%) | 38.82 | 37.72 | 40.94 | 37.28 | 35.41 |
| 收入构成(%) | |||||
| 处方药类(%) | 16.83 | 18.00 | 10.94 | 15.21 | 15.13 |
| 非处方药类(%) | 72.49 | 74.16 | 80.05 | 69.89 | 72.35 |
| 保健品及其他(%) | 10.68 | 7.84 | 9.00 | 14.89 | 12.52 |
| 毛利构成(%) | |||||
| 处方药类(%) | 10.88 | 11.06 | 7.85 | 14.73 | 15.53 |
| 非处方药类(%) | 82.89 | 84.32 | 86.83 | 76.76 | 77.97 |
| 保健品及其他(%) | 6.23 | 4.62 | 5.32 | 8.51 | 6.50 |